Clinical Trial Update: Study of Micafungin in Patients With Invasive Candidiasis or Candidemia [Phase 3]

View source ↗

Summary

A Phase 3 study of micafungin for invasive candidiasis or candidemia has completed, representing a completed trial update for this antifungal agent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia
• Candidiasis

Drugs mentioned

• Mycamine (Micafungin)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Candidiasis, Candidemia | Phase 3 | Status: COMPLETED